Blue Crest Capital Management LTD Ionis Pharmaceuticals Inc Transaction History

Blue Crest Capital Management LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$62.09 - $86.14 $2.17 Million - $3.01 Million	-34,935 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$52.92 - $81.17 $798,668 - $1.23 Million	15,092 Added 76.06%	34,935 $2.84 Million
Q4 2018 Feb 14, 2019	BUY	$43.37 - $59.54 $405,205 - $556,282	9,343 Added 88.98%	19,843 $1.07 Million
Q3 2018 Nov 14, 2018	BUY	$42.88 - $53.7 $450,240 - $563,850	10,500 New	10,500 $542,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Blue Crest Capital Management LTD with notifications on news.